Table 2.
NAA | Cr | Cho | Ins | Glx | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Region | ASD | HC | ASD | HC | ASD | HC | ASD | HC | ASD | HC |
Tha | ||||||||||
Left | 1.75 (0.4) | 1.77 (0.5) | 0.98 (0.1) | 1.06 (0.2) | 0.84 (0.1) | 0.83 (0.4) | 0.37 (0.1) | 0.37 (0.1) | 1.49 (0.3) | 1.58 (0.2) |
Right | 1.77 (0.4) | 1.72 (0.4) | 1.02 (0.1) | 0.94 (0.1) | 0.89 (0.1) | 0.84 (0.1) | 0.42 (0.2) | 0.44 (0.2) | 1.57 (0.5) | 1.90 (0.9) |
TPJ | ||||||||||
Left | 1.56 (0.4) | 1.83 (0.4) | 0.80 (0.2) | 0.95 (0.3) | 0.62 (0.2) | 0.77 (0.5) | 0.27 (0.1) | 0.45 (0.2) | 1.23 (0.7) | 1.41 (0.7) |
Right | 1.76 (0.5) | 2.14 (0.6) | 1.01 (0.1) | 1.00 (0.2) | 0.83 (0.3) | 0.72 (0.2) | 0.49 (0.1) | 0.49 (0.1) | 1.49 (0.5) | 1.67 (1.0) |
IPS | ||||||||||
Left | 1.76 (0.3) | 2.06 (0.7) | 0.95 (0.2) | 0.90 (0.2) | 0.62 (0.1) | 0.65 (0.2) | 0.40 (0.1) | 0.37 (0.1) | 1.12 (0.5) | 1.82 (1.3) |
Right | 1.79 (0.7) | 1.88 (0.5) | 0.80 (0.2) | 0.80 (0.1) | 0.52 (0.2) | 0.57 (0.2) | 0.29 (0.1) | 0.43 (0.1) | 1.51 (1.0) | 1.65 (0.7) |
ACC | ||||||||||
Left | 1.87 (0.3) | 1.91 (0.4) | 1.12 (0.3) | 1.12 (0.3) | 1.05 (0.2) | 1.17 (0.4) | 0.60 (0.3) | 0.52 (0.2) | 1.31 (0.4) | 1.41 (0.3) |
Right | 2.07 (0.4) | 2.20 (0.4) | 1.23 (0.3) | 1.17 (0.3) | 1.09 (0.2) | 1.13 (0.3) | 0.57 (0.3) | 0.79 (0.4) | 1.17 (0.4) | 1.76 (0.5) |
NAA, N-acetyl-aspartate; Cr, creatinine+phosphocreatinine, Cho, choline-containing compounds; Glx, glutamate+glutamine; Ins, myo-inositol; ACC, anterior cingulate cortex; IPS, intraparietal sulcus; TPJ, temporoparietal junction; Tha, thalamus; ASD, autism spectrum disorder; HC, healthy control.